Shareable Research Card

QNRX - Quoin Pharmaceuticals, Ltd. Interest Expense

This metric view shows QNRX - Quoin Pharmaceuticals, Ltd. interest expense history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: 2021
Latest reported value
$1,090,409

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2021
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: 2021.
  • Latest reported value on this page: $1,090,409.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Interest Expense

New fact period available

Latest reported interest expense: $1,090,409. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2021

Page type

Metric history

Latest period

2021

SEC-backed company facts were refreshed from filings filed on 07 May 2026.

Benchmark Context

How Interest Expense compares with peers

Quoin Pharmaceuticals, Ltd. is outside the visible top 120 companies for interest expense in the current sample.

Compared with

Compared with 120 companies reporting interest expense in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Interest Expense is up about 2219% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Sep 2018 to 30 Jun 2026.
  • Nearby companies in this sample: FEDERAL HOME LOAN MORTGAGE CORP and FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

Quoin Pharmaceuticals, Ltd.: Interest Expense

Latest period: 2021. Period end: 31 Dec 2021. Units: USD. Frequency: annual and quarterly.

Amount of the cost of borrowed funds accounted for as interest expense.

What this metric tells you

  • Shows reported interest expense over 31 Dec 2020 - 31 Dec 2021.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 3 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use annual sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Interest Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Report period Next step
1 FEDERAL HOME LOAN MORTGAGE CORP (fmcc) $108,417,000,000 Year - 31 Dec 2025 Open FEDERAL HOME LOAN MORTGAGE CORP Interest Expense
2 FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE (fnma) $29,775,000,000 Quarter - 31 Mar 2024 Open FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE Interest Expense
3 JPMORGAN CHASE & CO (jpm) $24,356,000,000 Quarter - 31 Mar 2024 Open JPMORGAN CHASE & CO Interest Expense
4 CITIGROUP INC (c) $22,494,000,000 Quarter - 30 Jun 2024 Open CITIGROUP INC Interest Expense
5 BANK OF AMERICA CORP /DE/ (bac) $22,253,000,000 Quarter - 31 Mar 2024 Open BANK OF AMERICA CORP /DE/ Interest Expense
6 HDFC BANK LTD (hdb) $18,405,600,000 Year - 31 Mar 2024 Open HDFC BANK LTD Interest Expense

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
USD
History range
31 Dec 2020 - 31 Dec 2021
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
3
Source: SEC company facts API
How to read it 1 detail
Metric definition
Amount of the cost of borrowed funds accounted for as interest expense.
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)
Interest Expense, Quarterly (USD)

Quoin Pharmaceuticals, Ltd. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $1,090,409 +$1,043,388 +2219% 01 Jan 2021 31 Dec 2021 20-F 14 Apr 2022 2021 FY
2020 $47,021 01 Jan 2020 31 Dec 2020 20-F 14 Apr 2022 2021 FY

Quoin Pharmaceuticals, Ltd. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2021 $202,514 01 Apr 2021 30 Jun 2021 6-K 18 Aug 2022 2022 Q2
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .